4.1 Article

Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat

Journal

ADDICTION BIOLOGY
Volume 16, Issue 1, Pages 20-29

Publisher

WILEY
DOI: 10.1111/j.1369-1600.2009.00199.x

Keywords

Conditioned response; context; dependence; opioid antagonist; psychostimulant; relapse

Funding

  1. Swedish Science Council [K2006-21X-14645-04-3]
  2. Swedish National Drug Policy Coordinator
  3. Karolinska Institutet

Ask authors/readers for more resources

Amphetamine, and other stimulants, readily induces behavioral sensitization, an effect hypothesized to reflect neurobiological changes that may underlie certain aspects of drug addiction. Apart from the effects on the dopamine system, previous studies have also shown that amphetamine interacts with other neurotransmitters, including the endogenous opioid system. The unselective opioid receptor antagonist naltrexone (NTX) modulates amphetamine-induced effects in both laboratory animals and humans. To further examine this interaction, the aim of the present study was to investigate the effect of NTX on the expression of locomotor sensitization and conditioned locomotor response in animals previously conditioned with amphetamine. Sensitization was induced by repeated administration of amphetamine (2 mg/kg) for 10 consecutive days. After a 10-day drug-free period, the rats were administered NTX (3 mg/kg) 30 minutes prior to the administration of a challenge dose of either amphetamine (0.5 mg/kg) (test for drug-induced sensitization) or saline (test for conditioned locomotor response). NTX had no effect on acute amphetamine-induced locomotor activity or on general locomotor activity in animals without a history of amphetamine conditioning. However, animals previously conditioned with amphetamine showed a sensitized locomotor response to the amphetamine challenge following the 10-day drug-free period. This sensitized response was significantly inhibited by NTX pre-treatment. In addition, NTX pre-treatment blocked the conditioned locomotor response when the amphetamine-conditioned animals were placed in the previously amphetamine-paired context. This study showed that NTX attenuates drug- and cue-induced locomotor behavior in amphetamine-conditioned animals, supporting recent clinical findings that indicated a potential role of NTX as a treatment for amphetamine dependence.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Ketamine-like effects of a combination of olanzapine and fluoxetine on AMPA and NMDA receptor-mediated transmission in the medial prefrontal cortex of the rat

Carl Bjorkholm, Kent Jardemark, Bjorn Schilstrom, Torgny H. Svensson

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)

Article Clinical Neurology

Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study

Monica M. Marcus, Carl Bjorkholm, Anna Malmerfelt, Annie Moller, Ninni Pahlsson, Asa Konradsson-Geuken, Kristin Feltmann, Kent Jardemark, Bjorn Schilstrom, Torgny H. Svensson

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)

Review Neurosciences

BDNF - a key transducer of antidepressant effects

Carl Bjorkholm, Lisa M. Monteggia

NEUROPHARMACOLOGY (2016)

Article Neurosciences

The Monoamine Stabilizer (-)-OSU6162 Attenuates Voluntary Ethanol Intake and Ethanol-Induced Dopamine Output in Nucleus Accumbens

Pia Steensland, Ida Fredriksson, Sarah Holst, Kristin Feltmann, Johan Franck, Bjorn Schilstrom, Arvid Carlsson

BIOLOGICAL PSYCHIATRY (2012)

Article Clinical Neurology

Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine

Carl Bjorkholm, Kent Jardemark, Monica M. Marcus, Anna Malmerfelt, Svante Nyberg, Bjorn Schilstrom, Torgny H. Svensson

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)

Article Clinical Neurology

Adjunctive Treatment with Asenapine Augments the Escitalopram-Induced Effects on Monoaminergic Outflow and Glutamatergic Neurotransmission in the Medial Prefrontal Cortex of the Rat

Carl Bjorkholm, Olivia Franberg, Anna Malmerfelt, Monica M. Marcus, Asa Konradsson-Geuken, Bjorn Schilstrom, Kent Jardemark, Torgny H. Svensson

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)

Article Multidisciplinary Sciences

Ghrelin Receptor (GHS-R1A) Antagonism Suppresses Both Alcohol Consumption and the Alcohol Deprivation Effect in Rats following Long-Term Voluntary Alcohol Consumption

Petra Suchankova, Pia Steensland, Ida Fredriksson, Jorgen A. Engel, Elisabet Jerlhag

PLOS ONE (2013)

Article Endocrinology & Metabolism

The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents

Emil Egecioglu, Pia Steensland, Ida Fredriksson, Kristin Feltmann, Jorgen A. Engel, Elisabet Jerlhag

PSYCHONEUROENDOCRINOLOGY (2013)

Article Neurosciences

Sustained effects of rapidly acting antidepressants require BDNF-dependent MeCP2 phosphorylation

Ji-Woon Kim, Anita E. Autry, Elisa S. Na, Megumi Adachi, Carl Bjorkholm, Ege T. Kavalali, Lisa M. Monteggia

Summary: This study shows that MeCP2 phosphorylation at a specific site downstream of BDNF is essential for the sustained antidepressant effects of ketamine and scopolamine, and plays a critical role in long-term regulation of synaptic strength. These findings highlight the importance of MeCP2 and associated synaptic plasticity in mediating sustained antidepressant effects of ketamine and scopolamine.

NATURE NEUROSCIENCE (2021)

Article Clinical Neurology

The novel antipsychotic drug brexpiprazole, alone and in combination with escitalopram, facilitates prefrontal glutamatergic transmission via a dopamine D1 receptor-dependent mechanism

Carl Bjorkholm, Monica M. Marcus, Asa Konradsson-Geuken, Kent Jardemark, Torgny H. Svensson

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)

Meeting Abstract Substance Abuse

PRECLINICAL EVALUATION OF GUANFACINE, AN ALPHA-2-ADRENOCEPTOR AGONIST, AS A POTEINTIAL NOVEL MEDICATION OF ALCOHOL USE DISORDER

P. Steensland, I. Fredriksson, E. Nystrom, E. Nylander, M. Wirf, N. Jayaram-Lindstrom

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2014)

Meeting Abstract Neurosciences

Preclinical Evaluation of the Monoamine Stabilizer (-)-OSU6162's Abuse Liability, Effect on Impulsivity and Dopamine Output in the N.Accumbens

Pia Steensland, Kristin Feltmann, Ida Fredriksson, Malin Wirf, Bjorn Schilstrom, Arvid Carlsson

BIOLOGICAL PSYCHIATRY (2014)

Meeting Abstract Substance Abuse

THE MONOAMINE STABILIZER (-)-OSU6162 ATTENUATES VOLUNTARY ETHANOL INTAKE AND ETHANOL-INDUCED DOPAMINE OUTPUT IN THE NUCLEUS ACCUMBENS

P. Steensland, I. Fredriksson, S. Holst, K. Feltmann, J. Franck, B. Schilstrom, A. Carlsson

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2013)

Meeting Abstract Substance Abuse

THE MONOAMINE STABILIZER (-)-OSU6162-A POTENTIAL NOVEL TREATMENT FOR ALCOHOL USE DISORDER

P. Steensland, I. Fredriksson, K. Feltmann, S. Holst, J. Franck, B. Schilstrom, A. Carlsson

ALCOHOL AND ALCOHOLISM (2013)

No Data Available